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Abstract
Background: Tuberculosis (TB) diagnosis continues to rely on sputum smear microscopy in many settings. We
conducted a meta-analysis to estimate the percentage of children and adults with tuberculosis that are sputum
smear positive.
Methods: We searched PubMed, MEDLINE, Embase, and Global Health databases for studies that included both
children and adults with all forms of active TB. The pooled percentages of children and adults with smear positive
TB were estimated using the inverse variance heterogeneity model. This review was registered in the PROSPERO
database under registration number CRD42015015331.
Results: We identified 20 studies meeting our inclusion criteria that reported smear positivity for a total of 18,316
children and 162,574 adults from 14 countries. The pooled percentage of paediatric TB cases that were sputum
smear positive was 6.8 % (95 % Confidence Interval (CI) 2.2–12.2 %), compared with 52.0 % (95 % CI 40.0–64.0 %)
among adult cases. Eight studies reported data separately for children aged 0–4 and 5–14. The percentage of
children aged 0–4 that were smear positive was 0.5 % (95 % CI 0.0–1.9 %), compared with 14.0 % (95 % CI 8.9–19.
4 %) among children aged 5–14.
Conclusions: Children, especially those aged 0–4, are much less likely to be sputum smear positive than adults.
National TB programs relying on sputum smear for diagnosis are at risk of under-diagnosing and underestimating
the burden of TB in children.
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Background
National tuberculosis (TB) programs focused on diagno-
sis and treatment of sputum smear positive, highly infec-
tious TB cases have historically under-estimated the
burden of TB in children, who frequently present with
smear negative, paucibacillary disease [1, 2]. Recent
years, however, have brought increasing attention to the
global burden of TB in children. Childhood TB was the
focus of the World TB Day in 2012, and in 2012 the
World Health Organization (WHO) published their first
estimates of the global burden of childhood TB [2, 3].
Sputum smear microscopy remains the primary
diagnostic tool available for bacteriologic diagnosis of
TB in both children and adults in most settings [4].
Although conventional wisdom holds that children
are less likely to present with smear positive TB than
adults, the relative values of these proportions are not
known with precision and systematic reviews of the
relative percentages of children and adults with TB
that are smear positive have not been conducted. We
need quantitative estimates of these percentages to
understand the extent to which national TB programs
that prioritise treatment of smear positive TB will
tend to under-serve their paediatric as well as adult
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populations. These estimates may also be used to
more accurately inform the global burden of child-
hood TB. WHO estimates in 2012 assumed a similar
degree of under-diagnosis and underreporting among
children and adults. This approach would tend to
under-estimate the burden of childhood TB if chil-
dren are in fact less likely to be smear positive [3].
Jenkins et al. [5] provided alternative estimates of
paediatric and adult rates of smear positivity based on
values from studies in Norway and the United States
[6, 7]; however, the specific values used in this ana-
lysis were subject to some debate [8, 9].
In this paper, we present a systematic review and
meta-analysis of the relative percentages of children and
adults with tuberculosis that are sputum smear positive.
We also assess the percentage of children that are smear
positive by age group (0–4 vs. 5–14). These percentages
will be useful for improving estimates of the global
burden of childhood TB and for helping to assess the
potential value of more sensitive diagnostic methods in
children and adults.
Methods
The authors followed the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA) stan-
dards of quality for reporting systematic reviews [10]. The
protocol for this study was registered in the PROSPERO
database under registration number CRD42015015331 on
January 12, 2015, prior to data extraction [11] and is
available in the Additional file 1.
Search strategy and selection criteria
We conducted a systematic search of MEDLINE
(OvidSP 1946 to November Week 1, 2014), Embase
(OvidSP 1974 to November Week 1, 2014), Global
Health (OvidSP 1910 to 2014 Week 45), and PubMed
online databases. All searches were conducted on No-
vember 19, 2014 and all results were limited to English.
Our search terms were designed to capture studies about
TB that included both children and adults and that
attempted to diagnose all forms of TB. We also included
search terms intended to capture the range of study de-
signs that we thought could be used to collect data that
could inform our estimates. We did not specifically in-
clude terms related to sputum smear microscopy to in-
crease the likelihood of finding data from studies for
which the sensitivity of smear microscopy was not the
primary objective.
We reviewed abstracts from this initial search using a
defined set of inclusion criteria. All studies that could
not be excluded with certainty based on the information
in the abstract were referred for full text review. Our in-
clusion criteria were as follows. First, all included studies
needed to provide primary data on the total number of
children and adults with TB, as well as the number of
those children and adults with smear-positive TB.
Studies should have used a cut-off age of 15 years to
distinguish between children and adults, with children
defined as age <15 years or, if not reported otherwise,
≤15 years. We excluded studies that did not include
at least 10 cases of active TB, including at least two
children and at least two adults. We also excluded
studies that restricted the ages of the included
children or adults (e.g. that excluded children age
<5 years), did not describe an attempt to diagnose all
forms of TB (i.e. pulmonary and extra-pulmonary), or
required bacteriological confirmation for TB diagnosis.
The latter condition was necessary as bacteriological
confirmation may be unavailable for a large propor-
tion of children with TB, reflecting the continued lack
of sufficiently sensitive diagnostic tests [1]. Finally, we
excluded studies that selected for participant infec-
tiousness or other health statuses or conditions
(excepting HIV) that could make the study population
unrepresentative of the general population of TB
cases. Our complete search strategy is included in the
Additional file 1.
Two reviewers (AK and RRN) double reviewed all
abstracts in EndNote X7 to rule out studies that clearly
did not meet our inclusion criteria, with discrepancies
mediated by a third reviewer (HEJ or TC) and uncertain
studies referred for full text review. The same reviewers
also double reviewed all full text articles.
Data extraction
Two reviewers (AK and RRN) performed double data ex-
traction and entry using Microsoft Excel. A third reviewer
(HEJ or TC) arbitrated any discrepancies between the two
reviewers.
From each study, we extracted the total number of
children, adults, smear-positive children, and smear-
positive adults with active TB. We also extracted data on
study location, design, and year, as well as, when available,
potential covariates including the prevalence of HIV, his-
tory of BCG, and history of previous TB among child and
adult participants. The majority of these covariates were
available only for a small subset of the included studies.
For studies that provided a finer age breakdown than child
vs. adult, we extracted the age range, total number of TB
cases, and number of smear-positive TB cases from each
age group.
Quality assessment
We developed a modified QUADAS-2 tool to assess the
quality of the included studies [12]. This tool is provided
in the Additional file 1.
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Statistical analysis
To calculate the percentage of childhood TB cases that
were smear positive, we defined the numerator as the
number of children reported as smear positive and the
denominator as the total number of children diagnosed
with TB. Because we were interested in estimating the
percentage of all childhood TB cases that were smear
positive, incorporating all reasons for the absence of a
smear positive result, we did not restrict our analysis to
patients in whom a smear test was conducted. When
smear results were clearly reported for only a subset of
the study population (e.g. only among new cases), we re-
stricted our analyses to this sub-population. We repeated
this procedure among adults to calculate the percentage
of adult cases that were smear positive.
We performed meta-analyses using the inverse-
variance heterogeneity (IVhet) model [13], which is spe-
cifically developed for meta-analyses with high hetero-
geneity, in place of a random effects model, which may
underestimate the width of the confidence intervals and
become increasingly unreliable as heterogeneity in-
creases. The IVhet model is implemented in the meta-
analysis package MetaXL [14]. We included stratifica-
tions by age and study design in our final analyses; other
potential stratification variables such as BCG and HIV
were also considered.
Notification data
In a parallel analysis, we extracted data on the total and
smear-positive numbers of children and adults from the
WHO TB case notification database [15]. Countries
started reporting both smear positive and smear negative
cases in 2006, and at the date of extraction not all data
for 2013 were available and we therefore restricted our
analysis to 2006–2012. We estimated the proportion of
children and adults with smear-positive TB for all
countries, OECD member countries, and countries with
WHO benchmark status. The same statistical approach
was used for the notification data as for the systematic
review.
Results
The following section presents results of our systematic
review and separate analysis of WHO notification data.
Description of included studies
The results of the literature search are displayed in Fig. 1.
Our initial search yielded 1371 abstracts. Of these, 317
were referred for full text review, and 20 full texts were
selected for inclusion in the qualitative synthesis and
meta-analysis [16–35]. Table 1 and Additional file 2
provide information on each of the included studies.
Two of the 20 included studies applied a cut-off
Fig. 1 Deatils of literature search leading to the selection of included studies
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Table 1 Summary of included studies
Data collection Design Number of Additional diagnostic methods
Name Location Start year End year Contact
tracing?




X-ray Culture Signs and
symptoms
Histopathology
Batra Pakistan 2008 2010 Children Only 121 1994 29 1089 Yes Unclear Yes Yes
Behera India 2002 2008 No 2549 25612 383 12984 Unclear Unclear Unclear Unclear
British Thoracic
Association A
United Kingdom 1973 1974 No 123 1114 30 214 Unclear Yes Unclear Yes
British Thoracic
Association B
United Kingdom 1973 1976 Yes 65 98 2 10 Yes Yes Yes Yes
Capewell United Kingdom 1977 1981 Yes 28 50 1 12 Yes Yes Unclear Unclear
Feldacker Malawi 2008 2010 No 338 10143 36 2704 Yes Unclear Yes Yes
Getahun Ethiopia 2004 2009 No 459 5991 58 1594 Yes Yes Yes Yes
Harries 1 Malawi 1998 1998 No 2739 20243 127 9335 Yes Unclear Yes Yes
Harries 2 Malawi 1986 1995 No 4691 14686 83 5609 Yes Unclear Yes Yes
Henegar Democratic
Republic of Congo







No 360 37272 111 24854 Unclear Unclear Unclear Unclear
Jackson-Sillah The Gambia 2002 2004 Yes 16 17 1 5 Yes Yes Yes Unclear
Khazaei Iran 1998 2002 No 163 2442 18 1329 Yes Unclear Yes Yes
Lienhardt Senegal 2004 2006 Yes 6 46 4 30 Yes Yes Yes Unclear
Lopez Angola 2009 2010 No 428 997 25 880 No No Yes Unclear
Mukherjee India 2008 2011 No 49 1182 11 809 Unclear Unclear Unclear Unclear
Norval Cambodia 1996 1996 No 150 6876 26 5923 Unclear Unclear Unclear Unclear
Rama Prakasha India 1995 2010 No 68 990 12 388 Yes Yes Yes Yes
Ramos Ethiopia 1998 2007 No 1029 1194 132 514 Yes Unclear Yes Yes
Tagaro Vanuatu 2007 2011 No 136 432 15 185 Yes Unclear Yes Unclear












age for children of ≤15 years [24, 28]; the remainder
defined the cut-off age for children as <15 years. The 20
included studies reported smear positivity for a total of
18,316 children and 162,574 adults across 14 countries.
The number of children included in each individual
study ranged from six to 4691. One of the 20 studies
included data on two distinct populations (adult and
child index cases as well as adult and child contacts);
these two populations were treated in the statistical
analysis as though they were derived from two different
studies [18].
Of the included studies, eight provided data on
child TB cases separately for younger and older
children (total and smear positive only), with a cut-off
age of 4 years. One of these eight studies used an age
cut-off for younger children of <4 years [29]; for the
remaining studies, the cut-off used was ≤4 years. The
eight studies included data on a total of 4922 children
in the younger age group and 2587 children in the
older age group.
Although we sought to extract data on several poten-
tial covariates including history of BCG vaccination, HIV
infection, and previous TB treatment, most studies did
not provide sufficient information to include these co-
variates in the analyses (Additional file 2). Data on BCG
vaccination was provided by only one of the 20 included
studies, and HIV infection by six (including two with
high rates of missing data).
Quality assessments of the included studies are pro-
vided in the Additional file 1. The included studies could
be broadly classified as either contact tracing studies or
retrospective record-based studies. We assessed contact
tracing studies as having a study population possibly not
representative of the general population of TB cases;
however, these studies often included extensive attempts
to accurately diagnose TB among children (Table 1). In
contrast, we assessed the majority of the record-based
studies as being sufficiently representative of the general
population of TB cases, but given the more limited
range of tests used to diagnose TB, these studies may
Percentage smear positive
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Percentage (95%CI) % Weight
   1.8 ( 1.4, 2.2) 25.60
3.1 ( 0.1, 9.1) 0.36
   3.6 ( 0.0, 14.7) 0.16
   4.6 ( 3.9, 5.5) 14.95
   4.9 ( 4.2,   5.6) 21.65
   5.8 (   3.8, 8.3) 2.34
6.3 ( 0.0, 24.9) 0.09
   6.8 ( 2.2, 12.2) 100.00
10.7 ( 7.6, 14.2) 1.85
11.0 ( 6.3, 16.9) 0.74
 11.0 (   6.6, 16.4) 0.89
12.6 (   9.7, 15.8) 2.51
12.8 ( 10.9, 14.9) 5.62
15.0 ( 13.7, 16.4) 13.91
17.0 ( 14.5, 19.6) 4.53
17.3 ( 11.7, 23.8) 0.82
17.6 ( 9.4, 27.7) 0.37
22.4 ( 11.7, 35.3) 0.27
 24.0 ( 16.7, 32.0) 0.66
24.4 ( 17.2, 32.4) 0.67
30.8 ( 26.2, 35.7) 1.97
66.7 ( 23.9, 98.5) 0.04
Fig. 2 Forest plot of smear positivity percentage among children
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have diagnosed TB in children with less reliability
(Table 1).
Pooled percentage smear positive: children vs. adults
Figures 2 and 3 show the smear positivity percentage
among children and adults respectively in the 20 in-
cluded papers. Results stratified by study design (contact
tracing vs record-based) are included in the Additional
file 1. We found a high degree of heterogeneity in the re-
sults across the included studies that could not be ex-
plained by differences in design (I2 ≥ 98 % for both
adults and children). Using the IVhet method to account
for this heterogeneity [13], we obtained a pooled esti-
mate for the percentage of TB cases with smear positive
disease of 6.8 % (95 % CI 2.2–12.2 %) among children
and 52.0 % (95 % CI 40.0–64.0 %) among adults.
Pooled percentage smear positive: younger children vs.
older children
Figure 4 depicts the smear positivity of younger and
older children respectively in the eight studies that pro-
vided data broken down into these two age groups (with
a cut-off age of 4 years). These results also display con-
siderable heterogeneity, though less so than the mea-
sures for children vs. adults (I2 = 85 % for younger
children and 77 % for older children). Using the IVhet
method to account for this heterogeneity [13], we ob-
tained a pooled estimate for the percentage of TB cases
with smear positive disease of 0.5 % (95 % CI 0.0–1.9 %)
among younger children aged 0–4 and 14.0 % (95 % CI
8.9–19.4 %) among older children aged 5–14.
Analysis of notification data
The results of our parallel analysis of WHO notification
data are included in the Additional file 1. Our examin-
ation of these data revealed a number of limitations, in-
cluding an unexpectedly high numbers of countries
reporting either 0 % or 100 % of cases to be smear posi-
tive; the high frequency of cases reported as “smear un-
known”; and the high variability in the proportion of
cases reported as “smear unknown” even among bench-
mark and OECD countries. Because of these limitations,
these data were not included in our primary analysis. Al-
though the age specific estimates of smear positivity
908070605040302010
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10.2 (   4.9, 17.1) 0.06
19.2 ( 16.9, 21.6) 0.69
24.0 ( 13.1, 36.9) 0.03
26.6 ( 25.5, 27.7) 3.69
26.7 ( 25.8, 27.5) 6.24
29.4 (   9.8, 53.6) 0.01
38.2 ( 37.4, 39.0) 9.03
39.2 ( 36.2, 42.3) 0.61
42.8 ( 38.2, 47.5) 0.27
43.0 ( 40.3, 45.9) 0.73
46.1 ( 45.4, 46.8) 12.45
47.5 ( 46.9, 48.1) 15.69
50.7 ( 50.1, 51.3) 15.75
52.0 ( 40.0, 64.0) 100.00
54.4 ( 52.4, 56.4) 1.50
54.6 ( 52.4, 56.8) 1.23
65.2 ( 50.8, 78.4) 0.03
65.7 ( 64.5, 66.9) 3.50
66.7 ( 66.2, 66.9) 22.93
68.4 ( 65.8, 71.1) 0.73
86.1 ( 85.3, 86.9) 4.23
88.3 ( 86.2, 90.2) 0.61
Study (first author last name) Percentage (95% CI) % Weight
Percentage smear positive
Fig. 3 Forest plot of smear positivity percentage among adults
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derived from these notification data vary by which coun-
tries are included in the analysis (see Additional file 1
for details), the overall results agree with our qualitative
assessment of substantially lower rates of smear positiv-
ity among children than among adults.
Discussion
In this study, we conducted a systematic review and meta-
analysis to assess the relative percentages of paediatric and
adult TB cases that present with sputum smear positive
TB. We estimated that just 6.8 % of paediatric TB cases
are sputum smear positive, compared with 52.0 % of
adults. Furthermore, we show that this percentage varies
greatly depending on the age of the children, with the per-
centage smear positive just 0.5 % among children aged 0–
4 compared with 14.0 % among children aged 5–14. Our
results are consistent with the assumptions of Jenkins et
al. [5], who assumed a smear positivity percentage of
8.8 % among childhood TB cases compared with 49.5–
56.6 % among adults when accounting for the under-
diagnosis of children to estimate the global burden of
childhood TB.
We found a high degree of heterogeneity across stud-
ies. The heterogeneity was reduced when we stratified
children into age groups of 0–4 and 5–14 years, suggest-
ing that differences in the age distributions across
studies may explain some of this variability. The age
structure of the included study populations was highly
heterogeneous, with the percentage of children age
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0.0 ( 0.0, 12.9) 0.27
0.0 ( 0.0, 27.0) 0.13
0.0 ( 0.0, 0.6) 6.04
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Fig. 4 Forest plots of smear positivity percentage among (a) younger children (ages 0-4 years) and (b) older children (ages 5-14 years)
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individual studies for which these data were available.
However, fewer than half of the included studies pro-
vided data on the age distribution of the included chil-
dren. The overall percentage of children with smear
positive TB is likely to vary depending on the age struc-
ture of the population of interest, as well as the average
age of infection. The percentage of paediatric TB cases
who are smear positive may also differ across settings
based on other factors such as the prevalence of HIV,
the prevalence of BCG vaccination, and the average
duration of disease prior to diagnosis. We were not able
to assess many of these factors in this meta-analysis
given the limited number of studies meeting the
inclusion criteria.
In defining the inclusion criteria, we were careful to
exclude studies that were clearly biased towards or
against the mostly highly infectious TB cases (e.g.
record-based studies from hospitals in which smear-
positive patients were routinely hospitalised; contact tra-
cing studies that reported data only on those adults with
at least one infected child contact). However, the in-
cluded study designs were not without limitations. Cases
discovered through contact tracing may be less severe
and less likely to be smear positive than those identified
through routine surveillance. On the other hand, routine
diagnosis of childhood TB, particularly in low-resource
settings, is often heavily reliant on clinical diagnosis and
thus may not represent the true burden of disease.
Though we extracted data on diagnosis patterns from
each study (Table 1), it was often difficult to assess the
degree to which diagnostic aggressiveness and willingness
to rely on clinical diagnosis differed across the included
studies. Concerns about the potential effects of study de-
sign on representativeness and over- or under-diagnosis of
TB cases are reflected in our quality assessments of the in-
cluded studies provided in the Additional file 1.
New tools and methods to diagnose TB in children are
needed given the low sensitivity of sputum smear
microscopy and lack of other inexpensive and reliable
methods in this highly vulnerable population. Recent stud-
ies have addressed the potential role of nucleic acid ampli-
fication tests such as Xpert MTB/RIF in diagnosing
paediatric TB [36, 37]. The sensitivity of Xpert MTB/RIF
among children appears to exceed that of smear micros-
copy; however, the sensitivity is still low among culture-
negative presumptive TB cases, which account for a large
fraction of the burden of TB among children [1, 36, 37].
Conclusions
The low percentages of smear positivity in this analysis
emphasise the degree to which national TB programs
dependent on sputum smear microscopy will need to
rely on clinical diagnoses of TB in children. Use of Xpert
MTB/RIF would likely reduce but not eliminate this
problem. Attempts to estimate the burden of TB in chil-
dren locally or globally should account for the relative
degree of under-diagnosis and underreporting caused by
the limitations of existing methods for diagnosing
childhood TB.
Additional file
Additional file 1 Supplemental information for A: Search strategies, B:
Rational for full text exclusions, C: Study quality assessment tool, D: Study
quality assessment results, E: Stratified results by age group, F: Stratified
results by study design, G: Challenges of using notification data, H:
Analysis of notification data. (DOCX 612 kb)
Additional file 2 Table of additional details for included studies. (XLSX
52 kb)
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